Cannabis Companies Seek to Nurture Growth in New Regions
Over the past few years, the cannabis market has overcome barriers and achieved milestones in what has been arguably its most important period ever. Notably, Canada's legalization of cannabis became recognized globally as the Country allowed the use of cannabis for its citizens, becoming the first G-7 nation to ever do so. Since then, other G-7 countries have also adopted some form of cannabis legislation. France, Germany, Italy, the U.K., and a majority of the U.S. have all implemented regulated medical cannabis legalization to a certain extent. Even while the U.S. has technically not ratified a federal bill legalizing cannabis for either medical or recreational use, its States have been given the jurisdiction to legalize cannabis or not. So far, more than half of U.S. states have legalized medical cannabis, while a fifth of the country has also moved to legalize its recreational use. The U.S. also remains the center of focus within the cannabis industry because it is still the primary revenue driver. States such as California, Colorado, Washington, Nevada deliver over billions of dollars collectively in annual cannabis sales, and furthermore, emerging states such as Oregon, Massachusetts, and Michigan are also expected to become large players within the marketplace. According to data compiled by Verified Market Intelligence, the global marijuana market was valued at USD 42.20 Billion in 2017. By 2025, the market is projected to reach USD 466.81 Billion, registering a CAGR of 35.3% from 2018 to 2025. WeedMD Inc. (OTC: WDDMF) (TSX-V: WMD), Pyxus International Inc. (NYSE: PYX), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), OrganiGram Holdings Inc. (OTC: OGRMF) (TSX-V: OGI), iAnthus Capital Holdings, Inc. (OTC: ITHUF) (CSE: IAN)
Cannabis Brief: Major Retail Stores Clearing Shelves to Carry CBD Infused Products
The projections for the legal & CBD cannabis markets seem to get higher with every new arrival and big box and brick & mortar retailers of all sizes have taken notice. The legal marijuana and CBD markets numbers are increasingly optimistic. Legal Marijuana: "Today, the U.S. is the epicenter of the legal cannabis market and it appears it will hold that position for the foreseeable future. By 2022, legal cannabis revenue in the U.S. market is projected to hit $23.4 billion." CBD: Add in the figures for the CBD markets: "Hemp-Derived CBD Will Outpace All Other Cannabis Markets, Projected to Hit $22 Billion by 2022" and it's easy to see why retailers want 'in' on the market. The CBD market is easier right now for the big box companies to get involved especially since CBD for medical use is legal in 46 states and CBD derived from hemp rather than marijuana is legal in all states. Active companies in the cannabis industry includes: CROP INFRASTRUCTURE CORP. (CSE:CROP) (OTC:CRXPF), MedMen Enterprises Inc. (CSE: MMEN) (OTC: MMNFF), CannTrust Holdings Inc. (TSX: TRST) (NYSE: CTST), The Yield Growth Corp. (CSE: BOSS) (OTC: BOSQF), OrganiGram Holdings Inc. (TSX-V: OGI) (OTC: OGRMF).
Cannabis Industry Projected Revenues Growing Faster Than Originally Expected
A Green Flower cannabis industry article started off with this amazing statement: "The cannabis market is booming these days, now operating legally in a number of states and countries across the globe." Another industry publication, the Marijuana Business Daily, supported this proposition, based on more states in the U.S. and more countries in the world, legalizing the industry. The article said: "I've been chronicling and analyzing this industry for the past seven-plus years. There will be a big crack in the marijuana legalization dam in the U.S. So much pressure is building up in significant areas - in the business community, in the investor world, in the general population, in this global movement - that lawmakers must start to pay more attention." One of the first such reports in The Rolling Stone, which said: "For years, experts have predicted that if the cannabis industry expands at its current rate, the American market will reach $20 billion by 2020. Active Companies from around the market with current developments this week include: Marijuana Company of America, Inc. (OTC:MCOA), PotNetwork Holdings, Inc. (OTC: POTN), OrganiGram Holdings Inc. (TSX-V: OGI) (OTC: OGRMF), CannTrust Holdings Inc. (TSX: TRST) (NYSE: CTST), Kona Gold Solutions, Inc. (OTC: KGKG).